NCT06577857Terminated
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 44 (actual)
- First submitted
- 27 Aug 2024
- Start date
- 4 Nov 2022
- Primary completion date
- 30 Jan 2025
- Lead sponsor
- Sanoculis Ltd
- Diseases
- Glaucoma
- NCT number
- NCT06577857
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- 1\. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment
Age in the registry: 40 years to 85 years · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| S. Malayan Eye Center Coordinator of this site? Confirm its status | Yerevan | Armenia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.